News Medical on MSN21h
Addressing COPD and metabolic syndrome requires comprehensive research effortsAdditional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
Fexlamose is being developed as a chronic treatment for COPD and asthma in conjunction with standard therapies, to improve ...
Young teens might think smoking makes them look cool, but it’s likely to take their breath away in adulthood, a new st ...
News Medical on MSN1d
Smoking before age 15 significantly increases risk of chronic lung diseaseA study reveals childhood smoking significantly increases COPD risk in adulthood, highlighting the need for targeted ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is needed to improve holistic patient care, according to a new editorial.
Individuals in the lowest quintile of birth weight appear to have an increased risk for subsequent chronic obstructive ...
In 2021,138,825 people died from COPD in the U.S., making it the sixth overall leading cause of death and the fifth ...
AZD-6793 is under clinical development by AstraZeneca and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).
TRN-157 is under clinical development by Theron Pharmaceuticals and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).
Childhood smoking before age 15 increases a person’s risk of developing chronic obstructive pulmonary disease (COPD), according to a new study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback